EUVIMEDEUVIMED entdecken
Crossref

Zhizichi decoction alleviates depressive-like behaviors through modulating mitochondria-associated membrane via the IP3R3-GRP75-VDAC1 complex

Ye Liu, Zicheng Zhang, Yimeng Zhao, Ruoyu Jiang, Zhihua Geng, Yujie Tao, Jiarui Zhang, Weiwei Tao

Journal of Ethnopharmacology · 2025

DOI: 10.1016/j.jep.2025.119628 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Ye Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address: liuye@njucm.ed…. Hauptthemen laut MEDLINE: Antidepressive Agents, Drugs, Chinese Herbal, Depression, Mitochondrial Membranes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Province Natural Science Foundation, Foundation for Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Zhizichi Decoction (ZZCD), a traditional Chinese medicine (TCM), is derived from the combination of Gardenia jasminoides J. Ellis [Rubiaceae] and Semen Sojae Praeparatum, a fermented derivative of Glycine max (L.) Merr. [Leguminosae]. ZZCD has demonstrated anti-inflammatory properties and the potential to promote neural plasticity. Neuroinflammation is believed to contribute to the development of depressive symptoms. AIM OF THE STUDY: This study investigates the potential antidepressant effects of ZZCD, focusing on its role in regulating neuroinflammatory responses and mitochondria-associated membrane (MAM) structure. MATERIALS AND METHODS: Using high-performance liquid chromatography (HPLC), we identified five active ingredients in ZZCD. We then evaluated its effect in a chronic social defeat stress (CSDS) mouse model. A combination of Network pharmacology analysis, Western-blot, immunostaining, enzyme-linked immunosorbent assay (ELISA), co-immunoprecipitation (CO-IP), mitochondrial transmembrane potential (ΔΨm), and transmission electron microscopy (TEM) was adopted to elucidate the mechanisms by which ZZCD improves MAM structure, inhibits neuroinflammation, and exerts antidepressant effects. Finally, according to the molecular docking results, a GRP75 overexpression viral vector was constructed to manipulate the MAM-related protein GRP75, further validating the mechanism of ZZCD's antidepressant effect. RESULTS: ZZCD treatment significantly ameliorated depressive-like behaviors induced by CSDS in mice and reversed adverse changes in endoplasmic reticulum (ER) stress, MAM structure, and mitochondria injury. In addition, ZZCD effectively reduced microglial inflammatory activation and suppressed the increased expression of pro-inflammatory cytokines. Finally, the antidepressant effects of ZZCD were primarily mediated through the IP3R3-GRP75-VDAC1 complex, as demonstrated by the overexpression of the GRP75 protein. CONCLUSION: In summary, ZZCD exerts antidepressant effects in the CSDS model by improving the MAM structure, alleviating neuroinflammation, and enhancing mitochondrial function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsDrugs, Chinese HerbalDepressionMitochondrial MembranesAnimalsMaleMiceBehavior, AnimalMice, Inbred C57BLDisease Models, AnimalMembrane ProteinsHSP70 Heat-Shock ProteinsMitochondriaMembrane Potential, MitochondrialSocial DefeatMitochondria Associated Membranes

Stichwörter der Autor:innen

Anti-depressantMAMsMitochondrialNetwork pharmacologyNeuroinflammationZhizichi decoction

Substanzen

Antidepressive AgentsDrugs, Chinese HerbalMembrane ProteinsHSP70 Heat-Shock Proteins

Autor:innen und Institutionen

  • School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address: liuye@njucm.edu.cn.
  • School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address: 065321136@njucm.edu.cn.
  • School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address: zym8772123456@163.com.
  • School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address: 19855171032@163.com.
  • School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address: gzh_726@163.com.
  • School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address: 19802620878@163.com.

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Province Natural Science Foundation
  • Foundation for Science and Technology

Zitieren

APA

Liu, Y., Zhang, Z., Zhao, Y., Jiang, R., Geng, Z., Tao, Y., Zhang, J., & Tao, W. (2025). Zhizichi decoction alleviates depressive-like behaviors through modulating mitochondria-associated membrane via the IP3R3-GRP75-VDAC1 complex. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.119628

Vancouver

Liu Y, Zhang Z, Zhao Y, Jiang R, Geng Z, Tao Y, et al. Zhizichi decoction alleviates depressive-like behaviors through modulating mitochondria-associated membrane via the IP3R3-GRP75-VDAC1 complex. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2025.119628

BibTeX
@article{Liu2025,
  author = {Liu, Ye and Zhang, Zicheng and Zhao, Yimeng and Jiang, Ruoyu and Geng, Zhihua and Tao, Yujie and Zhang, Jiarui and Tao, Weiwei},
  title = {Zhizichi decoction alleviates depressive-like behaviors through modulating mitochondria-associated membrane via the IP3R3-GRP75-VDAC1 complex},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  doi = {10.1016/j.jep.2025.119628}
}
Kostenlos starten →